Skip to content

Discontinuation of continuous renal replacement therapy in critically ill patients: A multicenter prospective observational study

Discontinuation of continuous renal replacement therapy in critically ill patients: A multicenter prospective observational study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060806
Enrollment
Unknown
Registered
2022-06-12
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute kidney injury

Interventions

Case series:NO

Sponsors

Affiliated Zhejiang Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Critically ill patients requiring CRRT for acute kidney injury (age >= 18 years); 2. Signed informed consent.

Exclusion criteria

Exclusion criteria: 1. End-stage renal disease (CKD5), regardless of whether renal replacement therapy has been performed before admission to ICU; 2. Received a kidney transplant; 3. Pregnancy; 4. The patient is in critical condition and expected to die within 72 hours; 5. Refusal to sign informed consent.

Design outcomes

Primary

MeasureTime frame
Successful discontinuation;

Secondary

MeasureTime frame
60-day mortality;60-day RRT-dependence;

Countries

China

Contacts

Public ContactLiang Xu
xu12141@126.com+86 13858160230

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026